NCT00233805View on ClinicalTrials.gov

The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.

PHASE2CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

December 31, 2007

Conditions

Coronary Artery Disease

Interventions

DEVICE

Sirolimus coated Bx Velocity™

drug-eluting stent

DEVICE

Bare metal Bx Velocity™

bare-metal stent

Trial Locations (1)

F- 91300

Dr Marie-Claude Morice, Massy

Sponsors

Lead Sponsor

Cordis Corporation

All Listed Sponsors

lead

Cordis Corporation

INDUSTRY

NCT00233805 - The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study. | Biotech Hunter | Biotech Hunter